tradingkey.logo

Progyny Inc

PGNY

21.060USD

+0.030+0.14%
Close 06/16, 16:00ETQuotes delayed by 15 min
1.80BMarket Cap
33.20P/E TTM

Progyny Inc

21.060

+0.030+0.14%
More Details of Progyny Inc Company
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Company Info
Ticker SymbolPGNY
Company nameProgyny Inc
IPO dateOct 25, 2019
Founded at2008
CEOMr. Peter (Pete) Anevski
Number of employees675
Security typeOrdinary Share
Fiscal year-endOct 25
Address1359 Broadway
CityNEW YORK
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code10018
Phone12128883124
Websitehttps://www.progyny.com/
Ticker SymbolPGNY
IPO dateOct 25, 2019
Founded at2008
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
256.37K
-3.02%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Ms. Allison Swartz
Ms. Allison Swartz
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.87K
-1.53%
Mr. Lloyd H. Dean
Mr. Lloyd H. Dean
Independent Director
Independent Director
19.73K
+68.59%
Ms. Cheryl M. Scott
Ms. Cheryl M. Scott
Independent Director
Independent Director
14.11K
-15.93%
Mr. Mark S. Livingston
Mr. Mark S. Livingston
Chief Financial Officer
Chief Financial Officer
11.69K
-15.76%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Peter (Pete) Anevski
Mr. Peter (Pete) Anevski
Chief Executive Officer, Director
Chief Executive Officer, Director
256.37K
-3.02%
Ms. Melissa Cummings
Ms. Melissa Cummings
Chief Operating Officer
Chief Operating Officer
41.67K
--
Mr. Jeffrey Gary (Jeff) Park
Mr. Jeffrey Gary (Jeff) Park
Lead Independent Director
Lead Independent Director
32.06K
+41.26%
Mr. Geoffrey Clapp
Mr. Geoffrey Clapp
Chief Product Officer
Chief Product Officer
28.69K
--
Mr. Kevin K. Gordon
Mr. Kevin K. Gordon
Independent Director
Independent Director
23.03K
+53.50%
Mr. Roger C. Holstein
Mr. Roger C. Holstein
Independent Director
Independent Director
21.94K
+57.70%
Revenue Breakdown
Currency: USDUpdated: Sun, Apr 6
Currency: USDUpdated: Sun, Apr 6
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
729.55M
62.50%
Pharmacy benefits services revenue
437.67M
37.50%
By RegionUSD
Name
Revenue
Proportion
United States
1.17B
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Fertility benefits services revenue
729.55M
62.50%
Pharmacy benefits services revenue
437.67M
37.50%
Shareholding Stats
Updated: Sun, Jun 8
Updated: Sun, Jun 8
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.86%
The Vanguard Group, Inc.
10.03%
Thrivent Asset Management, LLC
6.24%
Seidenberg (Beth C)
6.24%
Kleiner, Perkins, Caufield & Byers
5.92%
Other
58.71%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
12.86%
The Vanguard Group, Inc.
10.03%
Thrivent Asset Management, LLC
6.24%
Seidenberg (Beth C)
6.24%
Kleiner, Perkins, Caufield & Byers
5.92%
Other
58.71%
Shareholder Types
Shareholders
Proportion
Investment Advisor
42.50%
Investment Advisor/Hedge Fund
36.89%
Hedge Fund
7.84%
Individual Investor
7.63%
Venture Capital
5.93%
Research Firm
3.50%
Pension Fund
1.45%
Bank and Trust
0.39%
Family Office
0.09%
Institutional Shareholding
Updated: Tue, Mar 4
Updated: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
738
98.24M
114.05%
-17.82M
2024Q4
736
97.21M
113.81%
-18.60M
2024Q3
721
97.59M
108.87%
-13.76M
2024Q2
700
102.42M
113.70%
-10.92M
2024Q1
684
101.40M
106.22%
-3.55M
2023Q4
667
98.10M
102.55%
-7.56M
2023Q3
653
97.93M
102.95%
-1.75M
2023Q2
657
95.12M
99.98%
-10.18M
2023Q1
644
96.30M
102.13%
-5.85M
2022Q4
639
96.48M
103.42%
+2.81M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
11.96M
14.01%
-177.88K
-1.47%
Dec 31, 2024
The Vanguard Group, Inc.
8.67M
10.15%
+48.27K
+0.56%
Dec 31, 2024
Seidenberg (Beth C)
5.35M
6.26%
+7.21K
+0.13%
May 23, 2024
Kleiner, Perkins, Caufield & Byers
5.07M
5.94%
--
--
Dec 31, 2023
State Street Global Advisors (US)
3.14M
3.67%
+23.98K
+0.77%
Dec 31, 2024
Geode Capital Management, L.L.C.
1.83M
2.14%
-96.53K
-5.02%
Dec 31, 2024
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
Alger Weatherbie Enduring Growth ETF
3.33%
Invesco S&P SmallCap 600 GARP ETF
2.49%
SPDR S&P Health Care Services ETF
2.15%
Thrivent Small-Mid Cap ESG ETF
1.61%
Invesco S&P SmallCap Health Care ETF
1.1%
First Trust Small Cap US Equity Select ETF
1.03%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.83%
VictoryShares Small Cap Free Cash Flow ETF
0.67%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.66%
Langar Global HealthTech ETF
0.48%
View more
Alger Weatherbie Enduring Growth ETF
Proportion3.33%
Invesco S&P SmallCap 600 GARP ETF
Proportion2.49%
SPDR S&P Health Care Services ETF
Proportion2.15%
Thrivent Small-Mid Cap ESG ETF
Proportion1.61%
Invesco S&P SmallCap Health Care ETF
Proportion1.1%
First Trust Small Cap US Equity Select ETF
Proportion1.03%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.83%
VictoryShares Small Cap Free Cash Flow ETF
Proportion0.67%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proportion0.66%
Langar Global HealthTech ETF
Proportion0.48%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI